X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

ALLR

Closed

Allarity Therapeutics Inc

1.04
+0.03 (+2.97%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.01
Day's Range: 0.96 - 1.01
Send
When Written:
 
1.68
Allarity Therapeutics Inc is a clinical-stage biotechnology company that focuses on developing and commercializing personalized medicine for cancer patients. The company's proprietary drug response predictor platform, called DRP, uses a patient's unique genetic profile to predict which cancer drugs will be most effective for that individual. Allarity Therapeutics aims to improve the success rate of cancer treatments and reduce the time and costs associated with drug development. The company's lead product candidate, dovitinib, is currently in clinical trials for the treatment of advanced liver cancer and advanced breast cancer. Allarity Therapeutics is headquartered in Denmark and has operations in the United States.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X